Progesterone Receptor Negative Suspended Phase 2 Trials for Paclitaxel (DB01229)

IndicationStatusPhase
DBCOND0038639 (Progesterone Receptor Negative)Suspended2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02883062Carboplatin and Paclitaxel With or Without Atezolizumab Before Surgery in Treating Patients With Newly Diagnosed, Stage II-III Triple-Negative Breast CancerTreatment